Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.
J Am Soc Cytopathol. 2022 Jul-Aug;11(4):234-240. doi: 10.1016/j.jasc.2022.04.002. Epub 2022 Apr 19.
At our institution, palpation-guided fine-needle aspiration (FNA) is performed by the cytopathology service on an outpatient basis at the request of otolaryngologist surgeons. The aim of this study is to assess the effect of COVID lockdown measures on our FNA service with specific focus on adequacy rates.
All palpation-guided FNA performed in 2019 to 2020 were identified in our pathology database. Adequacy rates were compared for 3 time periods in 2020: pre-COVID, lockdown, and post-lockdown.
In 2019, 121 FNAs were performed with 98% (119 of 121) obtained by pathology and only 2% (2 of 121) obtained by surgeons. In 2020, 89 FNAs were performed with 45% (40 of 89) collected by pathologists and 55% (49 of 89) by surgeons. During the pre-COVID period of 2020, 27 FNAs were collected, 85% (23 of 27) by pathologists, 8.7% of these (2 of 23) were nondiagnostic. Of the 4 FNAs performed by surgeons, all were positive for malignancy. During COVID lockdown all 24 FNAs were performed by surgeons with a 50% (12 of 24) nondiagnostic rate. Post-lockdown, with FNA referrals still below pre-COVID levels, surgeons performed 55.3% (21 of 38) of FNAs with 28.6% (6 of 21) non-diagnostic, while pathology performed 44.7% (17 of 38) with an 11.8% (2 of 17) nondiagnostic rate.
Our FNA service noted significant changes in 2020 as a result of the COVID pandemic. Nondiagnostic rates were significantly increased in 2020 compared with 2019, primarily due to a shift to majority surgeon-performed palpation-guided FNA in the absence of cytopathology service during the lockdown period.
在我们的机构中，触诊引导下的细针抽吸 (FNA) 由细胞学服务部门在耳鼻喉科外科医生的要求下在门诊进行。本研究的目的是评估 COVID 封锁措施对我们的 FNA 服务的影响，特别是对充分性率的影响。
在我们的病理数据库中确定了 2019 年至 2020 年期间进行的所有触诊引导下的 FNA。比较了 2020 年三个时期的充分性率：COVID 前、封锁期间和封锁后。
2019 年，进行了 121 例 FNA，其中 98%（119/121）由病理医生获得，只有 2%（2/121）由外科医生获得。2020 年，进行了 89 例 FNA，其中 45%（40/89）由病理医生收集，55%（49/89）由外科医生收集。在 2020 年的 COVID 前期间，进行了 27 例 FNA，其中 85%（23/27）由病理医生收集，其中 8.7%（2/23）为非诊断性。在由外科医生进行的 4 例 FNA 中，所有均为恶性肿瘤阳性。在 COVID 封锁期间，所有 24 例 FNA 均由外科医生进行，其中 50%（12/24）为非诊断性。封锁后，随着 FNA 转介仍低于 COVID 前水平，外科医生进行了 55.3%（21/38）的 FNA，其中 28.6%（6/21）为非诊断性，而病理医生进行了 44.7%（17/38），其中 11.8%（2/17）为非诊断性。
由于 COVID 大流行，我们的 FNA 服务在 2020 年发生了重大变化。与 2019 年相比，2020 年的非诊断率显著增加，主要原因是在封锁期间缺乏细胞学服务的情况下，大多数外科医生进行触诊引导下的 FNA。
